Oct. 28, 2009
Monitor Online (Kampala, Uganda) covered the recent news of a $500,000 grant from USAID to the Hutchinson Center to help construct the first U.S. cancer clinic in Africa, a collaboration between the Hutchinson Center and the Uganda Cancer Institute.
http://www.monitor.co.ug/artman/publish/news/Mulago_receives_Shs900m_for_cancer_clinic_93683.shtml
Oct. 27, 2009
Associated Press ran a story about the Hutchinson Center/Uganda Cancer Institute collaboration to study and treat infectious disease-related cancers. The story quoted Dr. Corey Casper, an assistant member of VIDI and co-director of the Uganda Program for Cancer and Infectious Diseases, as well as current and former Ugandan physician trainees Drs. Fred Okuku and Amos Mwaka, who have come here to study with Dr. Casper and colleagues. It also mentions Dr. Victoria Walusansa, the program's first Ugandan trainee. Below is a link from The Boston Herald.
Oct. 23, 2009
The New York Times ran an article that mentioned Dr. Ira Longini's (VIDI member) prediction of when the H1N1 flu pandemic will peak in the U.S.
http://www.nytimes.com/2009/10/24/health/24flu.html?hpw
Oct. 20, 2009
Time magazine and MedPage Today ran articles on the the final results of a Thai HIV vaccine trial included comments from Dr. Nicole Frahm (VIDI assistant member). She attended this week's annual AIDS Vaccine Conference in Paris.
http://www.time.com/time/health/article/0,8599,1931470,00.html
http://www.medpagetoday.com/HIVAIDS/HIVAIDS/16531
Oct. 7, 2009
The Oregonian quoted Drs. Larry Corey (VIDI co-director) and Shelly Karuna (HVTN Protocol Team Leader) about the promising results of a recent Thai AIDS vaccine trial.
http://www.oregonlive.com/health/index.ssf/2009/10/partial_success_of_aids_vaccin.html
Sept. 29, 2009
Xconomy Seattle ran an editorial piece by Dr. Larry Corey (VIDI co-director) about why he's encouraged by findings from a clinical trial of an HIV vaccine that protected about one out of every three people tested.
http://www.xconomy.com/seattle/2009/09/29/the-quest-for-an-hiv-vaccine/